サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1392712

免疫グロブリンの世界市場レポート 2024年

Immunoglobulins Global Market Report 2024
出版日: 受注後更新 | 発行: The Business Research Company | ページ情報: 英文 200 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
免疫グロブリンの世界市場レポート 2024年
出版日: 受注後更新
発行: The Business Research Company
ページ情報: 英文 200 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 目次
概要

免疫グロブリン市場規模は近年力強く成長しています。2023年の174億9,000万米ドルから2024年には190億7,000万米ドルへと、CAGR9.1％で拡大します。過去の期間に観察された成長は、いくつかの要因に起因しています。これには、免疫不全疾患の有病率の増加、老年人口の増加、病院での免疫グロブリン採用の増加、有利な政府償還プラン、慢性疾患や自己免疫疾患の有病率の増加などが含まれます。これらの要因が総合的に免疫グロブリン市場の拡大に寄与しています。

2023年の免疫グロブリン市場で最大の地域は北米でした。アジア太平洋は予測期間中に最も急成長する地域となる見込みです。

目次

第1章 エグゼクティブサマリー

第2章 免疫グロブリン市場の特徴

第3章 免疫グロブリン市場の動向と戦略

第4章 免疫グロブリン市場- マクロ経済シナリオ

  • 高インフレが市場に与える影響
  • ウクライナ・ロシア戦争が市場に与える影響
  • COVID-19による市場への影響

第5章 世界の免疫グロブリン市場規模と成長

  • 市場促進要因・市場抑制要因
    • 市場促進要因
    • 市場抑制要因
  • 市場規模と成長実績、2018～2023年
  • 市場規模と成長予測、2023～2028年、2033F

第6章 免疫グロブリン市場セグメンテーション

  • 世界の免疫グロブリン市場、製品別セグメンテーション、実績および予測、2018-2023、2023-2028F、2033F
  • IGG
  • IGA
  • IGM
  • IGE
  • IGD
  • 世界の免疫グロブリン市場、配送モード別のセグメンテーション、実績および予測、2018-2023、2023-2028F、2033F
  • 静脈内送達方法
  • 皮下送達方法
  • 世界の免疫グロブリン市場、用途別セグメンテーション、実績および予測、2018-2023、2023-2028F、2033F
  • 低ガンマグロブリン血症
  • 慢性炎症性脱髄性多発神経障害（CIDP）
  • 免疫不全疾患
  • 重症筋無力症
  • 特発性血小板減少性紫斑病（ITP）
  • その他の用途

第7章 免疫グロブリン市場の地域および国の分析

  • 世界の免疫グロブリン市場、地域別、実績および予測、2018-2023、2023-2028F、2033F
  • 世界の免疫グロブリン市場、国別、実績および予測、2018-2023、2023-2028F、2033F

第8章 アジア太平洋の免疫グロブリン市場

  • 概要
  • 地域情報、COVID-19の影響、市場情報、背景情報、政府の取り組み、規制、規制機関、主要団体、課税額、法人税構造、投資、主要企業
  • 製品別のセグメンテーション、実績および予測、2018-2023、2023-2028F、2033F
  • 配信モード別のセグメンテーション、実績および予測、2018-2023、2023-2028F、2033F
  • 用途別のセグメンテーション、実績および予測、2018-2023、2023-2028F、2033F

第9章 中国の免疫グロブリン市場

第10章 インドの免疫グロブリン市場

第11章 日本の免疫グロブリン市場

第12章 オーストラリアの免疫グロブリン市場

第13章 インドネシアの免疫グロブリン市場

第14章 韓国の免疫グロブリン市場

第15章 西欧の免疫グロブリン市場

  • 概要
  • 製品別のセグメンテーション、実績および予測、2018-2023、2023-2028F、2033F
  • 配信モード別のセグメンテーション、実績および予測、2018-2023、2023-2028F、2033F
  • 用途別のセグメンテーション、実績および予測、2018-2023、2023-2028F、2033F

第16章 英国の免疫グロブリン市場

第17章 ドイツの免疫グロブリン市場

第18章 フランスの免疫グロブリン市場

第19章 イタリアの免疫グロブリン市場

第20章 スペインの免疫グロブリン市場

第21章 東欧の免疫グロブリン市場

  • 概要
  • 製品別のセグメンテーション、実績および予測、2018-2023、2023-2028F、2033F
  • 配信モード別のセグメンテーション、実績および予測、2018-2023、2023-2028F、2033F
  • 用途別のセグメンテーション、実績および予測、2018-2023、2023-2028F、2033F

第22章 ロシアの免疫グロブリン市場

第23章 北米の免疫グロブリン市場

  • 概要
  • 製品別のセグメンテーション、実績および予測、2018-2023、2023-2028F、2033F
  • 配信モード別のセグメンテーション、実績および予測、2018-2023、2023-2028F、2033F
  • 用途別のセグメンテーション、実績および予測、2018-2023、2023-2028F、2033F

第24章 米国の免疫グロブリン市場

第25章 カナダの免疫グロブリン市場

第26章 南米の免疫グロブリン市場

  • 概要
  • 製品別のセグメンテーション、実績および予測、2018-2023、2023-2028F、2033F
  • 配信モード別のセグメンテーション、実績および予測、2018-2023、2023-2028F、2033F
  • 用途別のセグメンテーション、実績および予測、2018-2023、2023-2028F、2033F

第27章 ブラジルの免疫グロブリン市場

第28章 中東の免疫グロブリン市場

  • 概要
  • 製品別のセグメンテーション、実績および予測、2018-2023、2023-2028F、2033F
  • 配信モード別のセグメンテーション、実績および予測、2018-2023、2023-2028F、2033F
  • 用途別のセグメンテーション、実績および予測、2018-2023、2023-2028F、2033F

第29章 アフリカの免疫グロブリン市場

  • 概要
  • 製品別のセグメンテーション、実績および予測、2018-2023、2023-2028F、2033F
  • 配信モード別のセグメンテーション、実績および予測、2018-2023、2023-2028F、2033F
  • 用途別のセグメンテーション、実績および予測、2018-2023、2023-2028F、2033F

第30章 免疫グロブリン市場の競合情勢と企業プロファイル

  • 免疫グロブリン市場の競合情勢
  • 免疫グロブリン市場の企業プロファイル
    • Baxter International Inc.
    • CSL Behring LLC
    • Grifols S. A.
    • Octapharma AG
    • China Biologic Products Holdings Inc.

第31章 世界の免疫グロブリン市場の競合ベンチマーキング

第32章 世界の免疫グロブリン市場の競合ダッシュボード

第33章 免疫グロブリン市場における主要な合併と買収

第34章 免疫グロブリン市場の将来展望と可能性分析

第35章 付録

目次
Product Code: r10400

“Immunoglobulins Global Market Report 2024 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on immunoglobulins market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for immunoglobulins? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The immunoglobulins market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

  • 1) By Product: IGG; IGA; IGM; IGE; IGD.
  • 2) By Mode Of Delivery: Intravenous Mode of Delivery; Subcutaneous Mode of Delivery
  • 3) By Application: Hypogammaglobulinemia; Chronic Inflammatory demyelinating polyneuropathy (CIDP); Immunodeficiency Disease; Myasthenia Gravis; Idiopathic thrombocytopenic purpura (ITP); Other Applications
  • Companies Mentioned: Baxter International Inc.; CSL Behring LLC; Grifols S. A.; Octapharma AG; China Biologic Products Holdings Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Immunoglobulins, also known as antibodies, are glycoproteins produced by plasma cells, a type of white blood cell. These molecules play a crucial role in the immune response by selectively identifying and binding to specific antigens, such as viruses or bacteria, contributing to their elimination from the body.

The primary types of immunoglobulins include IgG, IgA, IgM, IgE, and IgD. Immunoglobulin G (IgG) is particularly significant as it is the main stimulator of humoral immunity in extracellular fluids like blood, lymph, and saliva. Each type of immunoglobulin serves a distinct function in the immune system's defense against various pathogens. These immunoglobulins are administered through different modes of delivery, including intravenous and subcutaneous routes. They find applications in treating conditions such as hypogammaglobulinemia, chronic inflammatory demyelinating polyneuropathy (CIDP), immunodeficiency diseases, myasthenia gravis, idiopathic thrombocytopenic purpura (ITP), and others. The therapeutic use of immunoglobulins helps address deficiencies in the immune system and manage autoimmune disorders, enhancing the body's ability to fight infections and maintain overall health.

The immunoglobulins market research report is one of a series of new reports from The Business Research Company that provides immunoglobulins market statistics, including immunoglobulins industry global market size, regional shares, competitors with a immunoglobulins market share, detailed immunoglobulins market segments, market trends and opportunities, and any further data you may need to thrive in the immunoglobulins industry. This immunoglobulins market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The immunoglobulins market size has grown strongly in recent years. It will grow from $17. 49 billion in 2023 to $19. 07 billion in 2024 at a compound annual growth rate (CAGR) of 9. 1%. The growth observed in the historic period can be attributed to several factors. These include an increased prevalence of immunodeficiency disorders, a growing geriatric population, rising adoption of immunoglobulins in hospitals, favorable government reimbursement plans, and an increasing prevalence of chronic and autoimmune diseases. These factors collectively contributed to the expansion of the immunoglobulins market during that time.

The immunoglobulins market size is expected to see rapid growth in the next few years. It will grow to $28. 3 billion in 2028 at a compound annual growth rate (CAGR) of 10. 4%. The anticipated growth in the forecast period can be attributed to several factors. These include increasing investments in the development of advanced technologies, a growing awareness about immunodeficiency therapies, a rising preference among physicians for immunodeficiency therapies, an increasing number of emerging markets, and the expansion of applications in sports and fitness. These factors are expected to contribute to the continued expansion of the immunodeficiency therapy market in the forecasted period. Additionally, major trends in the forecast period include the development of wearable and smart compression devices, the customization of compression therapy solutions, the integration of compression therapy in wound care management, and an emphasis on patient comfort and compliance in compression therapy. Furthermore, collaborations between manufacturers and healthcare providers for improved patient outcomes are expected to shape the landscape of immunodeficiency therapies in the coming years. These trends indicate a dynamic and evolving market focused on technological advancements, personalized solutions, and enhanced patient care.

The growth of the immunoglobulins market is being propelled by the increasing geriatric population. This demographic is particularly susceptible to infectious and autoimmune diseases. Immunoglobulin tests are instrumental in assessing the body's ability to generate antibodies for safeguarding against bacteria, viruses, and allergies. For example, a report from the World Health Organization (WHO) in October 2022 revealed that by 2030, one in six individuals globally is projected to be 60 years or older. Additionally, it is estimated that by 2050, the worldwide population of individuals aged 60 or older will reach 2. 1 billion. Consequently, the rising geriatric population is anticipated to drive demand for the immunoglobulins market throughout the forecast period.

The anticipated growth of the immunoglobulins market is further supported by an increase in healthcare expenditure. Healthcare expenditure encompasses the total financial outlay by individuals, organizations, and governments on healthcare-related services, treatments, medications, medical equipment, facilities, and healthcare administration. Elevated investment in the healthcare sector fosters research and development activities in immunoglobulins, potentially leading to the discovery of advanced therapies and augmenting market growth. A report published by the Centers for Medicare & Medicaid Services in March 2022 estimated an average annual increase of 5. 1% in national health spending between 2021 and 2030, reaching nearly $6. 8 trillion. Moreover, Medicare and Medicaid spending is projected to rise at annual rates of 7. 2% and 5. 6%, respectively, during the same period. Consequently, the escalating healthcare expenditure is a driving force behind the growth of the immunoglobulins market.

The evolution of the immunoglobulins market is influenced by the establishment of new offices and laboratories dedicated to research and development activities. Key players in the immunoglobulins sector are strategically opening new laboratories to enhance platform technology, pipeline development, and manufacturing capabilities. For instance, in February 2021, VectorY, a fully integrated gene therapy firm, inaugurated offices and laboratories in the Netherlands. These facilities are focused on developing novel vectorized antibodies for treating muscular and neurological illnesses. VectorY employs a revolutionary AAV platform and antibody-based targeted degradation technology in collaborative projects aimed at overcoming the limitations of current therapies and improving delivery, durability, and accessibility to specific tissues and cells.

Major companies in the immunoglobulins market are actively developing innovative products, including intravenous immunoglobulins, to expand their customer bases, boost sales, and increase revenue. Intravenous immunoglobulin (IVIG) is a therapeutic product composed of a concentrated solution of immunoglobulins found naturally in blood plasma. For example, in February 2021, Pfizer Inc., a US-based pharmaceutical company, secured FDA approval for PANZYGA. This unique product is the sole intravenous immunoglobulin (IVIg) offering two FDA-approved maintenance dosing alternatives for chronic inflammatory demyelinating polyneuropathy (CIDP), effectively meeting the clinical needs of patients. PANZYGA also allows for infusion rates of up to 12 mg/kg/min and is designed for adult individuals suffering from CIDP.

In October 2022, AbbVie Inc., a US-based pharmaceutical company, completed the acquisition of DJS Antibodies Ltd. for an undisclosed amount. This strategic move is expected to enhance AbbVie's existing antibody research efforts, strengthen its immunology portfolio, and establish a significant presence in the bioscience hub of Oxford, UK. The acquisition provides AbbVie with access to the HEPTAD platform, complementing its robust capabilities in biotherapeutics research. Simultaneously, DJS plans to leverage AbbVie's extensive expertise in drug discovery to advance antibody therapeutics and explore novel biological insights, particularly in challenging targets like GPCRs that have proven resistant to biologics-based approaches. DJS Antibodies Ltd. is a UK-based company specializing in antibody therapeutics.

Major companies operating in the in the immunoglobulins market report are Baxter International Inc., CSL Behring LLC, Grifols S. A., Octapharma AG, China Biologic Products Holdings Inc., Kedrion SpA, LFB SA, Biotest AG, Sanquin Blood Supply Foundation, ADMA Biologics Inc., Option Care Health Inc., Shanghai RAAS Blood Products Co. Ltd., Antibody Solutions, Blood Diagnostic Pharma Inc., Bio Products Laboratory Ltd., Bio-Rad Laboratories Inc., Bio-Techne Corporation, Catalyst Biosciences Inc., Cytiva Corporation, Immunovant Inc., Kamada Ltd., Emergent BioSolutions Inc., Fresenius Kabi AG, GlaxoSmithKline plc, Johnson & Johnson Services Inc., Merck & Co. Inc., Pfizer Inc., Roche Holding AG, Samsung Bioepis Co. Ltd., Takeda Pharmaceutical Company Limited, Teva Pharmaceutical Industries Ltd., Zydus Cadila Healthcare Limited

North America was the largest region in the immunoglobulins market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the immunoglobulins market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the immunoglobulins market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Canada, Spain.

The immunoglobins market consists of sales of antibodies, glycoproteins, and antigens. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified)).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Table of Contents

1. Executive Summary

2. Immunoglobulins Market Characteristics

3. Immunoglobulins Market Trends And Strategies

4. Immunoglobulins Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Immunoglobulins Market Size and Growth

  • 5.1. Global Immunoglobulins Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Immunoglobulins Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Immunoglobulins Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Immunoglobulins Market Segmentation

  • 6.1. Global Immunoglobulins Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • IGG
  • IGA
  • IGM
  • IGE
  • IGD.
  • 6.2. Global Immunoglobulins Market, Segmentation By Mode Of Delivery, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Intravenous Mode of Delivery
  • Subcutaneous Mode of Delivery
  • 6.3. Global Immunoglobulins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hypogammaglobulinemia
  • Chronic Inflammatory demyelinating polyneuropathy (CIDP)
  • Immunodeficiency Disease
  • Myasthenia Gravis
  • Idiopathic thrombocytopenic purpura (ITP)
  • Other Applications

7. Immunoglobulins Market Regional And Country Analysis

  • 7.1. Global Immunoglobulins Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Immunoglobulins Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Immunoglobulins Market

  • 8.1. Asia-Pacific Immunoglobulins Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Immunoglobulins Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Immunoglobulins Market, Segmentation By Mode Of Delivery, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8. 4. Asia-Pacific Immunoglobulins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Immunoglobulins Market

  • 9.1. China Immunoglobulins Market Overview
  • 9.2. China Immunoglobulins Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Immunoglobulins Market, Segmentation By Mode Of Delivery, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9. 4. China Immunoglobulins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Immunoglobulins Market

  • 10.1. India Immunoglobulins Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Immunoglobulins Market, Segmentation By Mode Of Delivery, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Immunoglobulins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Immunoglobulins Market

  • 11.1. Japan Immunoglobulins Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.2. Japan Immunoglobulins Market, Segmentation By Mode Of Delivery, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Immunoglobulins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Immunoglobulins Market

  • 12.1. Australia Immunoglobulins Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Immunoglobulins Market, Segmentation By Mode Of Delivery, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Immunoglobulins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Immunoglobulins Market

  • 13.1. Indonesia Immunoglobulins Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Immunoglobulins Market, Segmentation By Mode Of Delivery, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Immunoglobulins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Immunoglobulins Market

  • 14.1. South Korea Immunoglobulins Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.2. South Korea Immunoglobulins Market, Segmentation By Mode Of Delivery, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Immunoglobulins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Immunoglobulins Market

  • 15.1. Western Europe Immunoglobulins Market Overview
  • 15.2. Western Europe Immunoglobulins Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Immunoglobulins Market, Segmentation By Mode Of Delivery, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15. 4. Western Europe Immunoglobulins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Immunoglobulins Market

  • 16.1. UK Immunoglobulins Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Immunoglobulins Market, Segmentation By Mode Of Delivery, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Immunoglobulins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Immunoglobulins Market

  • 17.1. Germany Immunoglobulins Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Immunoglobulins Market, Segmentation By Mode Of Delivery, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Immunoglobulins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Immunoglobulins Market

  • 18. 5. France Immunoglobulins Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18. 6. France Immunoglobulins Market, Segmentation By Mode Of Delivery, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18. 7. France Immunoglobulins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Immunoglobulins Market

  • 19. 9. Italy Immunoglobulins Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.10. Italy Immunoglobulins Market, Segmentation By Mode Of Delivery, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.11. Italy Immunoglobulins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Immunoglobulins Market

  • 20.13. Spain Immunoglobulins Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.14. Spain Immunoglobulins Market, Segmentation By Mode Of Delivery, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.15. Spain Immunoglobulins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Immunoglobulins Market

  • 21.1. Eastern Europe Immunoglobulins Market Overview
  • 21.2. Eastern Europe Immunoglobulins Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Immunoglobulins Market, Segmentation By Mode Of Delivery, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21. 4. Eastern Europe Immunoglobulins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Immunoglobulins Market

  • 22.1. Russia Immunoglobulins Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Immunoglobulins Market, Segmentation By Mode Of Delivery, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Immunoglobulins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Immunoglobulins Market

  • 23.1. North America Immunoglobulins Market Overview
  • 23.2. North America Immunoglobulins Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Immunoglobulins Market, Segmentation By Mode Of Delivery, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23. 4. North America Immunoglobulins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Immunoglobulins Market

  • 24.1. USA Immunoglobulins Market Overview
  • 24.2. USA Immunoglobulins Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Immunoglobulins Market, Segmentation By Mode Of Delivery, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24. 4. USA Immunoglobulins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Immunoglobulins Market

  • 25.1. Canada Immunoglobulins Market Overview
  • 25.2. Canada Immunoglobulins Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Immunoglobulins Market, Segmentation By Mode Of Delivery, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25. 4. Canada Immunoglobulins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Immunoglobulins Market

  • 26.1. South America Immunoglobulins Market Overview
  • 26.2. South America Immunoglobulins Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Immunoglobulins Market, Segmentation By Mode Of Delivery, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26. 4. South America Immunoglobulins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Immunoglobulins Market

  • 27.1. Brazil Immunoglobulins Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Immunoglobulins Market, Segmentation By Mode Of Delivery, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Immunoglobulins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Immunoglobulins Market

  • 28.1. Middle East Immunoglobulins Market Overview
  • 28.2. Middle East Immunoglobulins Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Immunoglobulins Market, Segmentation By Mode Of Delivery, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28. 4. Middle East Immunoglobulins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Immunoglobulins Market

  • 29.1. Africa Immunoglobulins Market Overview
  • 29.2. Africa Immunoglobulins Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Immunoglobulins Market, Segmentation By Mode Of Delivery, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29. 4. Africa Immunoglobulins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Immunoglobulins Market Competitive Landscape And Company Profiles

  • 30.1. Immunoglobulins Market Competitive Landscape
  • 30.2. Immunoglobulins Market Company Profiles
    • 30.2.1. Baxter International Inc.
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1. 4. Financial Performance
    • 30.2.2. CSL Behring LLC
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2. 4. Financial Performance
    • 30.2.3. Grifols S. A.
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3. 4. Financial Performance
    • 30.2. 4. Octapharma AG
      • 30.2. 4.1. Overview
      • 30.2. 4.2. Products and Services
      • 30.2. 4.3. Strategy
      • 30.2. 4. 4. Financial Performance
    • 30.2. 5. China Biologic Products Holdings Inc.
      • 30.2. 5.1. Overview
      • 30.2. 5.2. Products and Services
      • 30.2. 5.3. Strategy
      • 30.2. 5. 4. Financial Performance

31. Global Immunoglobulins Market Competitive Benchmarking

32. Global Immunoglobulins Market Competitive Dashboard

33. Key Mergers And Acquisitions In The Immunoglobulins Market

34. Immunoglobulins Market Future Outlook and Potential Analysis

  • 34.1 Immunoglobulins Market In 2028 - Countries Offering Most New Opportunities
  • 34.2 Immunoglobulins Market In 2028 - Segments Offering Most New Opportunities
  • 34. 3 Immunoglobulins Market In 2028 - Growth Strategies
    • 34.3.1 Market Trend Based Strategies
    • 34.3.2 Competitor Strategies

35. Appendix

  • 35.1. Abbreviations
  • 35.2. Currencies
  • 35.3. Historic And Forecast Inflation Rates
  • 35. 4. Research Inquiries
  • 35. 5. The Business Research Company
  • 35. 6. Copyright And Disclaimer